A New Subpopulation of Extracellular Vesicles Harvested from Osteogenically Induced Mesenchymal Stromal Cells of Surgical Site-Released Tissue
Biomolecules · 2026
DOI: 10.3390/biom16020289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Laura-Marie Joly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Orthopedics and Trauma Surgery, University of Duisburg-Essen, 45147 Essen, Germany. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Osteogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Impaired bone healing is a major challenge in orthopedic and trauma surgery, often causing long-term disability and high costs. While autologous bone grafting is the gold standard, it is limited by donor site morbidity, low availability, and surgical risks. As an alternative, surgical site-released tissue (SSRT) collected intraoperatively offers a readily available source of regenerative cells and bioactive factors. This study investigates the potential of SSRT-derived mesenchymal stromal cell (MSC)-like cells and their extracellular vesicles (EVs) to support bone healing in a cell-free approach. SSRT samples from 30 patients undergoing elective hip replacement were collected using a surgical vacuum filter. MSC-like cells were isolated and characterized based on International Society for Cellular Therapy (ISCT) criteria. Interestingly, many SSRT-derived MSC-like cells expressed CD34, a marker typically absent in cultured MSCs but linked to tissue-resident stromal cells, suggesting distinct regenerative properties. These cells also showed slow proliferation rates (P1: 8.7 ± 3.2 days; P2: 8.2 ± 5.4 days). EVs were isolated from osteogenically stimulated (EVsMSC/O+) and unstimulated (EVsMSC/O−) MSCs over three weeks. Antibody profiling revealed distinct cargo compositions, with a notable enrichment of CD13+ EVs in the stimulated group. Further in vivo and functional studies are needed to clarify underlying mechanisms and confirm therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair of Orthopedics and Trauma Surgery, University of Duisburg-Essen, 45147 Essen, Germany.
- Institute for Transfusion Medicine, University Hospital Essen, 45147 Essen, Germany.
- Department of Orthopaedics, Trauma and Reconstructive Surgery, Marien Hospital Mülheim a. d Ruhr, 45468 Mülheim a.d. Ruhr, Germany.
- Department of Orthopaedics, Trauma and Reconstructive Surgery, Philippus Stift, 45147 Essen, Germany.
ORCID-Profile: Tobias Tertel, Andrea Sowislok, Bernd Giebel
Zitieren
APA
Joly, L. M., Tertel, T., Sowislok, A., Giebel, B., & Jäger, M. (2026). A New Subpopulation of Extracellular Vesicles Harvested from Osteogenically Induced Mesenchymal Stromal Cells of Surgical Site-Released Tissue. Biomolecules. https://doi.org/10.3390/biom16020289
Vancouver
Joly LM, Tertel T, Sowislok A, Giebel B, Jäger M. A New Subpopulation of Extracellular Vesicles Harvested from Osteogenically Induced Mesenchymal Stromal Cells of Surgical Site-Released Tissue. Biomolecules. 2026. doi:10.3390/biom16020289
BibTeX
@article{Joly2026,
author = {Joly, Laura-Marie and Tertel, Tobias and Sowislok, Andrea and Giebel, Bernd and Jäger, Marcus},
title = {A New Subpopulation of Extracellular Vesicles Harvested from Osteogenically Induced Mesenchymal Stromal Cells of Surgical Site-Released Tissue},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020289}
}
EUVIMED